Cover Image
市場調查報告書

子宮頸部癌症取向診斷產品:開發平台分析

Cervical Cancer - Pipeline Review, 2015

出版商 GlobalData 商品編碼 344262
出版日期 內容資訊 英文 71 Pages
訂單完成後即時交付
價格
Back to Top
子宮頸部癌症取向診斷產品:開發平台分析 Cervical Cancer - Pipeline Review, 2015
出版日期: 2015年10月01日 內容資訊: 英文 71 Pages
簡介

在 本報告提供全球各國的企業、醫療機關等開發中的、子宮頸部癌症的診斷產品 (診斷設備、試劑等) 的開發中產品資訊相關分析、臨床實驗/產品開發的整體進展,及各階段/各地區的詳細趨勢、各企業/各產品的詳細資訊 (臨床實驗的進展階段、開始/結束時期、認證預測等)、近來的產品開發的動向、產業趨勢等彙整資訊為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)

第4章 子宮頸部癌症:現在開發中的開發中產品 (各企業)

  • 子宮頸部癌症的開發企業:開發中產品 (各開發階段)
  • 子宮頸部癌症:各開發階段的開發中產品一覽

第5章 子宮頸部癌症相關的企業、產品概要

  • Abbott Diagnostics
    • 開發中產品及現在進行中的臨床實驗概要
  • Arbor Vita Corporation
  • Becton, Dickinson and Company
  • BioMark Technologies Inc.
  • Biomoda, Inc. (Inactive)
  • Cepheid Company Overview
  • China Sky One Medical, Inc.
  • Cytosystems Ltd
  • Enzo Life Sciences, Inc.
  • Genisphere Inc.
  • Genomic Vision
  • GenomicTree, Inc.
  • Louisville Bioscience, Inc.
  • Matritech, Inc. (Inactive)
  • MDNA Life Sciences, Inc.
  • MDxHealth SA
  • Milagen, Inc.
  • NeoDiagnostix, Inc.
  • Neogenix Oncology, Inc.
  • Oncgnostics GmbH
  • OncoHealth Corporation
  • ONCOVEDA Cancer Research Center
  • Orion Genomics LLC
  • Preciva Incorporated
  • RCP Diagnostics, LLC (Inactive)
  • Roche Diagnostics International Ltd.
  • Roche mtm laboratories AG
  • Sysmex
  • University of Manchester
  • US Biomarkers, Inc.
  • Vanderbilt University
  • Vigilant Biosciences, Inc.
  • XEPTAGEN SpA

第6章 子宮頸部癌症:近來的市場趨勢

第7章 附錄

圖表一覽

目錄
Product Code: GDME0081EPD

GlobalData's Medical Devices sector report, "Cervical Cancer - Pipeline Review, 2015" provides an overview of Cervical Cancer diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cervical Cancer diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cervical Cancer diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cervical Cancer diagnostic tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cervical Cancer diagnostic tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Cervical Cancer Overview

3. Products under Development

  • 3.1. Cervical Cancer - Pipeline Products by Stage of Development
  • 3.2. Cervical Cancer - Pipeline Products by Territory
  • 3.3. Cervical Cancer - Pipeline Products by Regulatory Path
  • 3.4. Cervical Cancer - Pipeline Products by Estimated Approval Date

4. Cervical Cancer - Pipeline Products under Development by Companies

  • 4.1. Cervical Cancer Companies - Pipeline Products by Stage of Development
  • 4.2. Cervical Cancer - Pipeline Products by Stage of Development

5. Cervical Cancer Companies and Product Overview

  • 5.1. Abbott Diagnostics Company Overview
    • 5.1.1. Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Arbor Vita Corporation Company Overview
    • 5.2.1. Arbor Vita Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Becton, Dickinson and Company Company Overview
    • 5.3.1. Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. BioMark Technologies Inc. Company Overview
    • 5.4.1. BioMark Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Biomoda, Inc. (Inactive) Company Overview
    • 5.5.1. Biomoda, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Cepheid Company Overview
    • 5.6.1. Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. China Sky One Medical, Inc. Company Overview
    • 5.7.1. China Sky One Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Cytosystems Ltd Company Overview
    • 5.8.1. Cytosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Enzo Life Sciences, Inc. Company Overview
    • 5.9.1. Enzo Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Genisphere Inc. Company Overview
    • 5.10.1. Genisphere Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Genomic Vision Company Overview
    • 5.11.1. Genomic Vision Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. GenomicTree, Inc. Company Overview
    • 5.12.1. GenomicTree, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Louisville Bioscience, Inc. Company Overview
    • 5.13.1. Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Matritech, Inc. (Inactive) Company Overview
    • 5.14.1. Matritech, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. MDNA Life Sciences, Inc. Company Overview
    • 5.15.1. MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. MDxHealth SA Company Overview
    • 5.16.1. MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Milagen, Inc. Company Overview
    • 5.17.1. Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. NeoDiagnostix, Inc. Company Overview
    • 5.18.1. NeoDiagnostix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Neogenix Oncology, Inc. Company Overview
    • 5.19.1. Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Oncgnostics GmbH Company Overview
    • 5.20.1. Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. OncoHealth Corporation Company Overview
    • 5.21.1. OncoHealth Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. ONCOVEDA Cancer Research Center Company Overview
    • 5.22.1. ONCOVEDA Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. Orion Genomics LLC Company Overview
    • 5.23.1. Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Preciva Incorporated Company Overview
    • 5.24.1. Preciva Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. RCP Diagnostics, LLC (Inactive) Company Overview
    • 5.25.1. RCP Diagnostics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Roche Diagnostics International Ltd. Company Overview
    • 5.26.1. Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Roche mtm laboratories AG Company Overview
    • 5.27.1. Roche mtm laboratories AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Sysmex Corporation Company Overview
    • 5.28.1. Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. University of Manchester Company Overview
    • 5.29.1. University of Manchester Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. US Biomarkers, Inc. Company Overview
    • 5.30.1. US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Vanderbilt University Company Overview
    • 5.31.1. Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Vigilant Biosciences, Inc. Company Overview
    • 5.32.1. Vigilant Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. XEPTAGEN SpA Company Overview
    • 5.33.1. XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview

6. Cervical Cancer- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Cervical Cancer - Pipeline Products by Stage of Development
  • Table 2: Cervical Cancer - Pipeline Products by Territory
  • Table 3: Cervical Cancer - Pipeline Products by Regulatory Path
  • Table 4: Cervical Cancer - Pipeline Products by Estimated Approval Date
  • Table 5: Cervical Cancer Companies - Pipeline Products by Stage of Development
  • Table 6: Cervical Cancer - Pipeline Products by Stage of Development
  • Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: TERT Companion Diagnostic Assay - Cervical Cancer - Product Status
  • Table 9: TERT Companion Diagnostic Assay - Cervical Cancer - Product Description
  • Table 10: Arbor Vita Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: AVantage HPV E6 Test - Product Status
  • Table 12: AVantage HPV E6 Test - Product Description
  • Table 13: Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: BD SurePath Plus Molecular Pap Test System - Product Status
  • Table 15: BD SurePath Plus Molecular Pap Test System - Product Description
  • Table 16: BioMark Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Biomarker Assay - Cervical Cancer - Product Status
  • Table 18: Biomarker Assay - Cervical Cancer - Product Description
  • Table 19: Biomoda, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: CyPath Diagnostic Assay - Cervical Cancer - Product Status
  • Table 21: CyPath Diagnostic Assay - Cervical Cancer - Product Description
  • Table 22: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Xpert Molecular PAP Assay - Product Status
  • Table 24: Xpert Molecular PAP Assay - Product Description
  • Table 25: China Sky One Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Diagnostic Kit - Carcinoma Cervix - Product Status
  • Table 27: Diagnostic Kit - Carcinoma Cervix - Product Description
  • Table 28: Cytosystems Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Laboratory-Based Diagnostic Test - Cervical Cancer - Product Status
  • Table 30: Laboratory-Based Diagnostic Test - Cervical Cancer - Product Description
  • Table 31: Enzo Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Next-Generation Branched DNA Assay - Cervical Cancer - Product Status
  • Table 33: Next-Generation Branched DNA Assay - Cervical Cancer - Product Description
  • Table 34: Genisphere Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: miRNA Biomarker Diagnostic Test - Cervical Cancer - Product Status
  • Table 36: miRNA Biomarker Diagnostic Test - Cervical Cancer - Product Description
  • Table 37: Genomic Vision Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: HPVCombing Test - Product Status
  • Table 39: HPVCombing Test - Product Description
  • Table 40: GenomicTree, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: OncoFinder Cervical Cancer-Prognostic Test - Product Status
  • Table 42: OncoFinder Cervical Cancer-Prognostic Test - Product Description
  • Table 43: Louisville Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Cervical Cancer Remission pT Test - Product Status
  • Table 45: Cervical Cancer Remission pT Test - Product Description
  • Table 46: Matritech, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: NMP179 Test - Product Status
  • Table 48: NMP179 Test - Product Description
  • Table 49: MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Diagnostic Test - Cervical Cancer - Product Status
  • Table 51: Diagnostic Test - Cervical Cancer - Product Description
  • Table 52: MDxHealth SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: ClinicalMDx - Cervical Cancer - Product Status
  • Table 54: ClinicalMDx - Cervical Cancer - Product Description
  • Table 55: Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: Immunoassay - Cervical Cancer - Product Status
  • Table 57: Immunoassay - Cervical Cancer - Product Description
  • Table 58: NeoDiagnostix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Cervical DNA Dtex Test - Product Status
  • Table 60: Cervical DNA Dtex Test - Product Description
  • Table 61: Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Diagnostic Assay - Cervical Cancer - Product Status
  • Table 63: Diagnostic Assay - Cervical Cancer - Product Description
  • Table 64: Oncgnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: GynTect - Product Status
  • Table 66: GynTect - Product Description
  • Table 67: OncoHealth Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: HPV E6 Analyte Specific Reagents Kit - Product Status
  • Table 69: HPV E6 Analyte Specific Reagents Kit - Product Description
  • Table 70: ONCOVEDA Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: Diagnostic Test - Cervical Cancer - Product Status
  • Table 72: Diagnostic Test - Cervical Cancer - Product Description
  • Table 73: Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Diagnostic Assay - Cervical Cancer - Product Status
  • Table 75: Diagnostic Assay - Cervical Cancer - Product Description
  • Table 76: Preciva Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: Electronic Cervical Cancer Screening Test - Product Status
  • Table 78: Electronic Cervical Cancer Screening Test - Product Description
  • Table 79: RCP Diagnostics, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: RCP-Dx Test - Cervical Cancer - Product Status
  • Table 81: RCP-Dx Test - Cervical Cancer - Product Description
  • Table 82: Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: CINtec Plus Cytology Kit - Product Status
  • Table 84: CINtec Plus Cytology Kit - Product Description
  • Table 85: Roche mtm laboratories AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: Cervatec ELISA - Product Status
  • Table 87: Cervatec ELISA - Product Description
  • Table 88: Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: Cervical Cancer Screening Test - Product Status
  • Table 90: Cervical Cancer Screening Test - Product Description
  • Table 91: University of Manchester Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: Diagnostic Test - Cervical Cancer - Product Status
  • Table 93: Diagnostic Test - Cervical Cancer - Product Description
  • Table 94: US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: Blood-Based Biomarker - Cervical Cancer - Product Status
  • Table 96: Blood-Based Biomarker - Cervical Cancer - Product Description
  • Table 97: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 98: Companion Diagnostic Assay - Cervical Cancer - Product Status
  • Table 99: Companion Diagnostic Assay - Cervical Cancer - Product Description
  • Table 100: Vigilant Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 101: Diagnostic Test - Cervical Cancer - Product Status
  • Table 102: Diagnostic Test - Cervical Cancer - Product Description
  • Table 103: XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 104: SCCA - IgM Kit - Cervical Cancer - Product Status
  • Table 105: SCCA - IgM Kit - Cervical Cancer - Product Description
  • Table 106: Glossary

List of Figures

  • Figure 1: Cervical Cancer - Pipeline Products by Stage of Development
  • Figure 2: Cervical Cancer - Pipeline Products by Territory
  • Figure 3: Cervical Cancer - Pipeline Products by Regulatory Path
  • Figure 4: Cervical Cancer - Pipeline Products by Estimated Approval Date
Back to Top